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Abstract
Type 2 Diabetes mellitus (Type 2 DM) is a metabolic disorder characterized by an increase in blood sugar caused 
by decreased insulin secretion by pancreatic beta cells and/or impaired insulin function (insulin resistance). 
This study aimed to determine the specific levels of estradiol hormone in reproductive age women with diabetes 
mellitus in different age groups. This was an analytical study in  September at Royal Prima Hospital, North Sumatra, 
Indonesia. Twenty women participated in this study after informed consent and were divided into two age 
groups: 40–45 years old and 46–50 years old.  Blood samples were collected after 10–12 hours of fasting to assess 
blood sugar and estradiol hormone levels. Data were then analyzed using the dependent t-test dependent and 
compared. No significant difference in blood sugar level was found between the two age groups (p-value=0.113, 
p-value >0.05) that there were no significant differences in blood sugar levels between the two age groups. The 
estradiol hormone level in the age group 40–45 years was lower than in the age group 46–50 years, and the 
difference was significant (p-value=0.000, p-value<0.05). No significant correlation was seen between type 2 DM 
and estradiol hormone level in this study. In conclusion, age is not the main contributing factor for the increase 
and decrease in blood sugar level, and type 2 DM does not correlate with estradiol hormone.
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Hubungan Antara Kadar Glukosa Darah dan Kadar Estradiol Pada 
Masa Reproduktif
Abstrak
Diabetes melitus (DM) Tipe 2 adalah penyakit gangguan metabolik yang ditandai oleh kenaikan gula darah akibat 
penurunan sekresi insulin oleh sel beta pankreas dan atau ganguan fungsi insulin (resistensi insulin). Penelitian 
ini bertujuan mengetahui kadar hormon estradiol wanita reproduktif yang menderita diabetes mellitus pada 
kelompok usia yang berbeda. Penelitian ini merupakan penelitian analitik yang dilakukan pada September 2019 
di Rumah Sakit Royal Prima, North Sumatera, Indonesia. Sebanyak 20 wanita berpartisipasi dalam penelitian ini 
setelah mendapat persetujuan dan dibagi atas dua kelompok usia, 40–45 tahun dan 46–50 tahun. Sampel darah 
diambil setelah 10–12 jam puasa untuk menilai kadar gula darah dan hormon estradiol. Data kemudian dianalisis 
menggunakan t-test dependent dan dibandingkan. Tidak terdapat perbedaan kadar gula darah antara kedua 
kelompok usia (p=0.113; p>0.05) sehingga tidak ada perbedaan kadar gula darah yang bermakna. Kadar hormon 
estradiol pada kelompok usia 40–45 tahun memiliki kadar estadiol lebih rendah dibanding dengan kelompok usia 
46–50 tahun. Tidak terdapat korelasi antara DM tipe 2 dan hormon estradiol yang bermakna pada  penelitian ini. 
Simpulan, bahwa usia bukan merupakan faktor penyebab utama peningkatan dan penurunan kadar gula darah 
dan DM tipe 2 tidak berhubungan dengan hormon estradiol.
Kata kunci: Diabetes melitus tipe 2, hormon, kadar estradiol
Majalah Kedokteran Bandung, Volume 52 No. 3, September 2020140
D Lionardi et al.: Correlation Between Blood Glucose and Estradiol Levels in Women in Reproductive Age
Introduction
Type 2 Diabetes mellitus (type 2 DM) is a 
metabolic disorder characterized by an increase 
in blood sugar caused by decreased insulin 
secretion by pancreatic beta cells and/or 
impaired insulin function (insulin resistance).1,2 
Type 2 Diabetes mellitus patients require long-
term care and treatment to prolong life and 
improve the quality of life.3
In the Diabetes Atlas 2019 (International 
Diabetes Federation), it is recorded that there 
were 463 million populations with type 2 DM 
in the world in 2019, which is predicted to 
increase with time. It is estimated that in 2045, 
the number of type 2 DM cases would reach 
629 million populations. This disease ranks the 
seventh leading cause of death in developing 
countries.4
Almost 80% of diabetics live in low and 
middle income countries. Based on IDF data in 
2017, Indonesia ranks sixth globally as a country 
with the highest prevalence of diabetes after 
China, India, the United States, Brazil, and Mexico 
with 10 million people living with diabetes in 
2015. The prevalence of people with diabetes in 
Indonesia tends to increase from 5.7% in 2007 
to 6.9% in 2013. With this trend, it is estimated 
that in 2045, there will be 16.7 million diabetics 
in the age group of 20–79 years in Indonesia.4,5,6
Type 2 DM links to the estrogen hormones, 
or 17β-estradiol (estradiol). During the 
reproductive age, where the production of 
this hormone is done continuously, estradiol 
protects beta pancreas cells from apoptosis and 
prevents insulin deficiency. This explains the 
lower prevalence of diabetes in women, showing 
the protective role of female sex steroids protect 
against pancreatic β-cell injury when compared 
to male hormones.7
Estrogen is a carbon steroid hormone 18 
that consists of estrone (E1), estradiol (E2), and 
estriol (E3). The most potent estrogen is estradiol, 
which is a product of the ovary. Estron is the 
primary product of androstenedione conversion 
and can also be produced in the liver through 
the transformation of 17 β-hydroxysteroid 
dehydrogenases from estradiol. Estradiol is 
mainly seen in the bound form with a carrier 
protein in the bloodstream. Albumin carries 
about 60% of estradiol, while globulin binds 
38% of estradiol and the remaining 2% is free in 
the bloodstream.8
A study that was performed on rats given 
estradiol-deficient or estradiol-resistant with 
impaired target aromatase (ArKO) or ERα 
(αERKO) also demonstrated that, in both sexes, 
ArKO -/-, mice are susceptible to β-cell apoptosis 
and responsive to insulin-deficient diabetes 
after exposure to acute stress oxidative with 
streptozotocin. In mice, estradiol treatment 
saves streptozotocin-induced β cell apoptosis, 
helps maintain insulin production, and prevents 
diabetes.7,9
In vitro, in rat pancreas and β cells exposed to 
stress oxidative, estradiol inhibits apoptosis and 
protects insulin secretion. Estradiol protection is 
lost in β cells and treated with ERα antagonists 
and in αERKO. Therefore, αERKO mice are no 
longer protected by estradiol and show sex-
specific susceptibility to oxidative damage, 
accelerating β cell apoptosis, and leading to 
insulin deficiency diabetes. The tendency of 
insulin insufficiency can be replicated in mice 
by pharmacological inhibition of ERα using 
fenantagonis tamoxi. This previous study showed 
that estradiol, which acts through ERα, protects B 
cells from oxidative injury, and prevents diabetes 
in mice of both sexes.7
With this in mind, this study aims to explore 
the possibility of hormone estradiol remains 
protective and prevents apoptosis in the 
pancreatic beta, or vice versa, and the disruption 
of the estradiol hormone.suffering from type 
2 diabetes mellitus in people living with type 2 
diabetes.
Methods
This analytical study was carried out at Royal 
Prima Hospital Medan (North Sumatera, 
Indonesia) in September 2019 to assess the 
relationship of type 2 Diabetes Mellitus with the 
hormone estradiol in women of reproductive age 
and approved by the Ethics Committee (038/
KEPK/UNPRI/IX/2019). 
Accidental sampling was applied and resulting 
in 20 subjects with type 2 diabetes mellitus at 
Royal Prima Hospital as subjects. The patients 
were given informed consent regarding this 
study. After they gave consent, blood collection 
in 20 patients was be carried out simultaneously 
at PATHLAB Medan after fasting for 10–12 hours 
to check fasting blood sugar levels and estradiol 
hormone levels.
Inclusion criteria used were women aged 40–
50 years with diabetes mellitus, outpatients or 
inpatients. Exclusion criteria were patients with 
hypertension, autoimmune diseases, cancer, and 
other comorbidities.
All statistical analyses were performed using 
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Table 1 Characteristics of Type 2 DM Patients 
  at Royal Prima Hospital
Age Group Frequency(n=20)
40–45 years 6 
46–50 years 14 








Table 3 Blood Sugar Level by Age Group
Age Group
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SPSS version 20.0. Significant results were 
reflected with a P-value of less than 0.05. Before 
analysis, data were analyzed for normality 
using the Shapiro-Wilk test and when the 
distribution was normal, the average difference 
of the two numeric variables was tested using 
the t-independent test. In order to assess the 
relationship between the independent variable 
and the dependent variable, the correlation test 
was used.
Results 
The subjects of this study were 20 women with 
type 2 diabetes mellitus, with the majority were 
46–50 years (n=14) with the remaining subjects 
(30%) aged 40–45 years (Table 1).
An analysis of data normality using the 
Shapiro-Wilk test was conducted, showing that 
the estradiol levels were normally distributed. 
Thus, analysis was continued using the 
t-independent test (Table 2). 
The average estradiol levels in the younger 
age group (40–45 years) were lower than those 
in the older age group (46–50 years). From the 
results of the T-Independent test analysis, it was 
revealed that the p-value was <0.05 (p-value 
=0.000), showing a statistically significant 
difference between the two groups.
In contrast to the estradiol level, the blood 
sugar level test results did not demonstrate a 
statistically different blood sugar level between 
the two age group as seen in Table 3. This was 
apparent from the resulting p-value of 0.113 
(p-value >0.05).
The analysis was then continued by assessing 
the relationship between the blood sugar 
level (173.75±39.26) and estradiol level 
(665.03±305.21) in blood using the correlation 
test, resulting a P-value of 0.240. This showed 
that there was no statistically significant 
correlation between in the blood sugar level 
and estradiol level although the correlation 
coefficient of 0.275 showed a weak correlation 
between the blood sugar level and estradiol 
level, albeit insignificant. 
Discussion
Type 2 DM were more prevalent in patients 
aged 46–50 years, which comprised 70% in this 
study, with the remaining subjects aged 40–45. 
The blood sugar level was higher in patients 
aged 46-50 (184.93±31.39) than in those who 
were 40–45 years old (147.67±46.12). Likewise, 
the estradiol level among those who were over 
46 years old was higher (792.80±275.15) than 
those under 45 years (366.90±69.14).
These findings were in line with a study 
conducted by Heianza et al.,10 which stated that 
a person aged ≥45 years has an increased risk of 
developing type 2 DM due to a reduced number 
of productive β cells caused by decreased body 
function.11
Age also has a close connection with the 
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increase and decrease of the hormone estradiol. 
This complies with a study conducted by Puspita 
et al., stating that the younger the age, the lower 
the hormone estradiol level as this hormone is 
responsible for the role of preparing the uterus 
for implantation and fetal growth.12 This is 
also supported by the theory stating that there 
is excessive production of androgens by the 
ovaries and adrenal glands in premenopausal 
age, which are then converted into estrogen by 
the aromatase enzyme found in adipose and 
fat tissue. This condition becomes the reason 
estradiol hormone increases in premenopausal 
age.13 The results of these previous studies and 
theories are in line with our results, as listed in 
Table 2, showing that at the age of 40–45 years, 
the hormone estradiol level is lower than in the 
age of 46–50. 
However, when viewed from blood sugar 
levels, age does not directly contribute to blood 
sugar level. As can be seen in Table 3, there is 
no significant difference between the two age 
groups. This is consistent with a study conducted 
by Chentli et al.,14 which suggested that when 
people get older, a decrease in muscle mass will 
be observed. Therefore, the older people may 
experience a loss of muscle strength, which may 
contribute indirectly to reduced ability in doing 
normal activities. Reduced physical activities 
and muscle mass may cause a build-up of fat in 
the body, which then lead to insulin resistance, 
increasing the weight of the individual.15 
Overweight individuals may experience changes 
in the glucose levels of glucagon plasma 
and insulin. They may face disruption in the 
development of insulin resistance, and the 
resulting diabetes is caused more by changes in 
body composition than aging.9,16,17
In type 2 DM, the presence of hormone 
estradiol plays a role as a pancreatic beta 
protector from apoptosis. However, in this study, 
the relationship between the hormone estradiol 
and type 2 DM is relatively weak. This correlation 
is increasingly supported by Gyllenhammer et 
al., who declares that physical activities have a 
close connection with the increase and decrease 
in estradiol levels in reproductive age. When a 
person rarely does physical activities, the level of 
estradiol will be higher for the individual.17,18
In addition to physical activities, the 
relationship between diet and hormone estradiol 
is also quite strong. It is stated in a study conducted 
by Sapre et al.19 that diet affects the synthesis of 
hormone estradiol. It is recommended to eat 
foods high in fiber to maintain the stability of 
hormone estradiol. Many factors can also affect 
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